LISI

2025 was another year of significant growth for LISI, with revenue up 11.5%.

The group delivered a robust financial showing, while at the same time strategically refocusing its business. Its performance was led by the Aerospace division (18.3% revenue growth), buoyed by a strong order book in a favourable aerospace market, which drove an increase in profitability (with the margin widening to 12% of revenue).

The Automotive division held firm, with revenue edging down just 0.6% despite a persistently weak global market. In line with its strategy of refocusing its business on Fasteners and on its two core divisions, the group sold the LISI Medical division during the year. The sale of this division streamlined the group’s portfolio and enabled it to strengthen its financial structure by scaling back debt. The year-end saw LISI included in the SBF 120 index following the increase in its free float due to Peugeot Invest's divestment, and thanks to LISI's solid business model.

Peugeot Invest Assets has not held a seat on LISI’s Board of Directors since 8 September 2025, following its open-market sale of 5.8% of LISI’s share capital. Peugeot Invest Assets sold its remaining shares in LISI on 13 February 2026 and therefore no longer holds any shares in the company.